Nicole Lambert Myriad Genetics Inc (MYGN) insider trading activity

Nicole Lambert is Chief Operating Officer of MYRIAD GENETICS INC. Currently has a direct ownership of 223,993 shares of MYGN, which is worth approximately $3.43 Million. The most recent transaction as insider was on Oct 09, 2023, when has been sold 12,111 shares (Common Stock) at a price of $15.01 per share, resulting in proceeds of $181,786. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 224K

0% 3M change

0% 12M change

Total Value Held $3.43 Million

Nicole Lambert Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 09 2023	SELL Payment of exercise price or tax liability	$181,786 $15.01 p/Share	12,111 Reduced 5.13%	223,993 Common Stock
Sep 26 2023	SELL Payment of exercise price or tax liability	$70,387 $15.99 p/Share	4,402 Reduced 1.83%	236,104 Common Stock
Mar 27 2023	SELL Open market or private sale	$151,046 $23.48 p/Share	6,433 Reduced 2.61%	240,506 Common Stock
Mar 24 2023	SELL Payment of exercise price or tax liability	$124,933 $23.72 p/Share	5,267 Reduced 2.09%	246,939 Common Stock
Mar 22 2023	SELL Payment of exercise price or tax liability	$55,419 $22.91 p/Share	2,419 Reduced 0.95%	252,206 Common Stock
Mar 15 2023	BUY Grant, award, or other acquisition	-	39,405 Added 13.4%	254,625 Common Stock
Mar 02 2023	SELL Open market or private sale	$299,804 $22.74 p/Share	13,184 Reduced 5.77%	215,220 Common Stock
Jan 01 2023	SELL Payment of exercise price or tax liability	$12,377 $14.51 p/Share	853 Reduced 0.37%	228,404 Common Stock
Oct 09 2022	SELL Payment of exercise price or tax liability	$237,755 $19.62 p/Share	12,118 Reduced 5.02%	229,257 Common Stock
Sep 26 2022	SELL Payment of exercise price or tax liability	$54,309 $18.41 p/Share	2,950 Reduced 1.21%	241,375 Common Stock
Sep 25 2022	SELL Payment of exercise price or tax liability	$11,999 $18.69 p/Share	642 Reduced 0.26%	244,325 Common Stock
Aug 25 2022	SELL Payment of exercise price or tax liability	$28,175 $24.89 p/Share	1,132 Reduced 0.46%	244,967 Common Stock
Mar 24 2022	SELL Payment of exercise price or tax liability	$135,386 $25.32 p/Share	5,347 Reduced 2.13%	246,099 Common Stock
Mar 22 2022	BUY Grant, award, or other acquisition	-	33,665 Added 11.81%	251,446 Common Stock
Feb 16 2022	BUY Grant, award, or other acquisition	-	43,295 Added 16.58%	217,781 Common Stock
Dec 08 2021	BUY Grant, award, or other acquisition	-	10,000 Added 5.42%	174,486 Common Stock
Oct 09 2021	SELL Payment of exercise price or tax liability	$385,475 $30.88 p/Share	12,483 Reduced 7.07%	164,169 Common Stock
Oct 01 2021	SELL Open market or private sale	$44,829 $31.57 p/Share	1,420 Reduced 0.8%	176,652 Common Stock
Sep 27 2021	SELL Open market or private sale	$334,707 $33.1 p/Share	10,112 Reduced 5.37%	178,072 Common Stock
Sep 26 2021	SELL Payment of exercise price or tax liability	$114,120 $33.31 p/Share	3,426 Reduced 1.79%	188,184 Common Stock
Sep 25 2021	SELL Payment of exercise price or tax liability	$43,669 $33.31 p/Share	1,311 Reduced 0.68%	191,610 Common Stock
Sep 21 2021	BUY Grant, award, or other acquisition	-	65,870 Added 25.45%	192,921 Common Stock
Aug 27 2021	SELL Open market or private sale	$32,602 $34.5 p/Share	945 Reduced 0.74%	127,051 Common Stock
Aug 25 2021	SELL Payment of exercise price or tax liability	$39,092 $34.81 p/Share	1,123 Reduced 0.87%	127,996 Common Stock
Apr 19 2021	SELL Open market or private sale	$179,589 $27.01 p/Share	6,649 Reduced 4.9%	129,119 Common Stock

Also insider at

RCUS

Arcus Biosciences, Inc. Healthcare

Director

Nicole Lambert

Chief Operating Officer

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Value

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to MYRIAD GENETICS INC

Track Activities on MYGN

Account